Teleflex Incorporated (NYSE:TFX) Receives $134.57 Average Price Target from Analysts

by · The Markets Daily

Shares of Teleflex Incorporated (NYSE:TFXGet Free Report) have earned a consensus recommendation of “Reduce” from the twelve research firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $138.1429.

Several research firms have weighed in on TFX. Royal Bank Of Canada lowered their target price on Teleflex from $135.00 to $120.00 and set a “sector perform” rating on the stock in a research note on Friday, November 7th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research report on Monday. Zacks Research lowered shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 30th. Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Finally, Wells Fargo & Company upped their price objective on shares of Teleflex from $114.00 to $139.00 and gave the stock an “equal weight” rating in a report on Wednesday.

Get Our Latest Stock Report on Teleflex

Hedge Funds Weigh In On Teleflex

Large investors have recently made changes to their positions in the business. Thurston Springer Miller Herd & Titak Inc. grew its holdings in Teleflex by 242.9% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after buying an additional 153 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its position in shares of Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 77 shares during the period. Brooklyn Investment Group grew its stake in shares of Teleflex by 258.6% in the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 150 shares during the last quarter. Hantz Financial Services Inc. increased its position in Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after acquiring an additional 199 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new position in Teleflex during the 3rd quarter valued at $35,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Down 0.4%

TFX stock opened at $126.69 on Wednesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53. The firm has a market capitalization of $5.60 billion, a P/E ratio of -17.24, a P/E/G ratio of 1.52 and a beta of 0.95. Teleflex has a 52-week low of $102.58 and a 52-week high of $185.94. The company’s 50 day simple moving average is $120.22 and its 200-day simple moving average is $120.93.

Teleflex (NYSE:TFXGet Free Report) last posted its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The firm had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. During the same period in the previous year, the company posted $3.49 EPS. The company’s quarterly revenue was up 19.4% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities research analysts anticipate that Teleflex will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Friday, November 14th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Friday, November 14th. Teleflex’s dividend payout ratio is -18.50%.

Teleflex Company Profile

(Get Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles